Yinmei Dai

Dr. Yinmei Dai

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 April 2025 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
YCYuting Cao
Yuting Cao
JWJianhong Wu
Jianhong Wu
JHJinyuan Huang
Jinyuan Huang
XFXiaoyin Fan
Xiaoyin Fan
YZYi Zhang
Yi Zhang
YDYinmei Dai
Yinmei Dai
Intrauterine adhesion (IUA) refers to endometrial fibrosis resulting from endometrial injury and infection. In promoting the repair of the endometrium, mesenchymal stem cells therapy has shown great potential. However, adult-derived mesenchymal stem cells (MSCs) are associated with several challenges, including invasive manipulation, susceptibility to contamination, and low proliferative capacity. Immunity-and-matrix-regulatory cells (IMRCs) derived from human embryonic stem cells exhibit enhanced immunomodulatory and anti-fibrotic capabilities. Despite their success in treating lung injury and fibrosis, membranous nephropathy, and acute liver failure, their therapeutic potential in IUA remains undetermined. TGF-β1-induced human endometrial stromal cells (HESCs) were utilized to construct the IUA cell model and were treated with IMRCs conditioned medium. Morphological changes in the cells were observed, and RT-qPCR and Western blot analyses were employed to detect the expression of relevant markers during the process of epithelial-mesenchymal transition (EMT) in vitro. The IUA rat model was established using the dual injury method and subsequently treated with intrauterine infusion of IMRCs. HE and Masson staining were used to assess endometrial damage, repair and the extent of fibrosis. Fertility assays were performed to compare the effectiveness of IMRCs and umbilical cord mesenchymal stem cells (UCMSCs) in improving endometrial function in IUA rats. Sequencing analysis of IMRCs-derived exosomes (Exos) was conducted to identify specific miRNAs and the pathways they target. TGF-β1 treatment induced HESCs to undergo fibrotic transformation and express fibrosis-related markers, while treatment with IMRCs conditioned medium inhibited TGF-β1-induced fibrosis. IUA rats were treated with intrauterine infusion of IMRCs. IMRCs facilitated the repair of damaged endometrium, restored the structure of the uterine cavity, and reduced collagen deposition. IMRCs reversed the process of endometrial EMT in rats with IUA, upregulated the expression of epithelial markers, and downregulated the expression of mesenchymal markers. IMRCs further exerted antifibrotic effects by reducing inflammatory responses. Fertility recovery in rats receiving intrauterine infusion of IMRCs was superior to that in rats receiving intrauterine infusion of UCMSCs. Specific miRNAs in Exos, including miR-27b-3p, miR-145-5p, and miR-16-5p, directly target Smad2, inhibit Smad2 phosphorylation, and modulate the TGF-β/Smad pathway. Our study demonstrated that IMRCs inhibited TGF-β1-induced fibrosis in HESCs, suppressed the EMT process ex vivo, reduced the inflammatory response, and reversed endometrial damage and fibrosis in IUA rats. IMRCs exerted their effects through the paracrine pathway, with specific miRNAs in Exos downregulating the TGF-β/Smad signaling pathway to inhibit uterine endometrial fibrosis. IMRCs provide a new direction for the treatment of IUA.

27 August 2021 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
YTYu‐Cui Tian
Yu‐Cui Tian
QWQian Wang
Qian Wang
HWHong‐Mei Wang
Hong‐Mei Wang
JWJian‐Hong Wu
Jian‐Hong Wu
YDYinmei Dai
Yinmei Dai

10 May 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
ZJZiwen Jiang
Ziwen Jiang
HTHong-Bo Tang
Hong-Bo Tang
QXQingqing Xiong
Qingqing Xiong
MLMin Li
Min Li
YDYinmei Dai
Yinmei Dai
ZZZhimin Zhou
Zhimin Zhou

1 October 2025 in Current Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
YCYuting Cao
Yuting Cao
JHJinyuan Huang
Jinyuan Huang
XFXiaoyin Fan
Xiaoyin Fan
YDYinmei Dai
Yinmei Dai
Background: Premature Ovarian Failure (POI), a prevalent gynecological, endocrine disease, significantly impairs the reproductive health of women of childbearing age and presents a formidable challenge to clinicians. Until now, there has been a lack of effective treatments to fundamentally improve ovarian function in patients with POI. Stem cell therapy has emerged as a promising treatment in the field of POI, with notable research progress achieved to date. Objective: This review sought to analyze the current status and hotspots of research on stem cell therapy for POI, forecasting future directions through bibliometrics. Methods: Research related to stem cell therapy for POI from 2000 to 2023 was searched in the Web of Science Core Collection (WOSCC) database by setting subject-term, and the literature was analyzed econometrically using VOSviewer, CiteSpace, and the R package "bibliometrix." Results: According to our search and screening strategy, 203 pieces of literature related to stem cell therapy for POI were obtained and analyzed. There is a marked annual increase in publications, with a particularly rapid ascent in recent years. China has become the most prolific country in this field, with 136 publications. Shanghai Jiao Tong University ranked first among many universities and institutions in terms of the number of publications and citations. Stem Cell Research & Therapy was the most popular and influential journal in the field of stem cell therapy for POI. Lai Dongmei has published the most papers, while Liu Te boasts the highest frequency of co-citations. Investigation into the mechanisms of exosomes derived from stem cells and their associated signaling pathways is anticipated to be a crucial research topic in stem cell therapy for POI. Conclusion: This review offers the first comprehensive and systematic analysis of the field of stem cell therapy for POI, with a visual representation of the findings. By summarizing the current status and projecting forthcoming trends, this study aims to offer guidance and a reference for scholars in the field.

1 April 2024 in Acta Biochimica et Biophysica Sinica
Verified
Journal Article
Open access
PDF file
JWJianhong Wu
Jianhong Wu
LFLinyuan Fan
Linyuan Fan
LLLin Li
Lin Li
YZYudi Zhang
Yudi Zhang
YTYucui Tian
Yucui Tian
YDYinmei Dai
Yinmei Dai